Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Blood|March 6, 2002
The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cellsChryso Kanthou, Gillian M TozerInternational Journal of Experimental Pathology|July 1, 2009
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologiesChryso Kanthou, Gillian M TozerSeminars in Radiation Oncology|July 16, 2004
Therapeutic targeting of the tumor vasculatureGillian M Tozer, Roy BicknellExpert Opinion on Therapeutic Targets|November 22, 2007
Tumour targeting by microtubule-depolymerizing vascular disrupting agentsChryso Kanthou, Gillian M TozerAnti-Cancer Drugs|March 5, 2005
From bench to bedside for gene-directed enzyme prodrug therapy of cancerGabi U Dachs, Joanna Tupper, Gillian M TozerNature Reviews. Cancer|June 2, 2005
Disrupting tumour blood vesselsGillian M Tozer, Chryso Kanthou, Bruce C BaguleyExperimental Biology and Medicine (Maywood, N.J.)|April 24, 2003
Effects of tin-protoporphyrin IX on blood flow in a rat tumor modelAmel F Khelifi, Vivien E Prise, Gillian M TozerMethods in Molecular Biology (Clifton, N.J.)|May 14, 2016
Quantitative Estimation of Tissue Blood Flow RateGillian M Tozer, Vivien E Prise, Vincent J CunninghamMethods in Molecular Biology (Clifton, N.J.)|March 24, 2009
Quantitative estimation of tissue blood flow rateGillian M Tozer, Vivien E Prise, Vincent J CunninghamPharmaceutical Research|March 10, 2018
Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic LiposomesJasmin Monpara, Chryso Kanthou, Gillian M Tozer, et al.Pageof 6